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Breast cancer slogan reality check: ‘‘1 in 9’’ – If you’re 90! Misuse of ‘‘1 in 9’’
slogan defended by two leading organisations’ directors on grounds
of consistency and popularity‘‘Should consistency trump accuracy?’’ – was the important,
probing question asked by Dr. Margaret McCartney during
a recently reported discussion with the two women in the UK
best placed to relay information to women about breast cancer.1
Professor Julietta Patnick, director of the NHS Breast Cancer
Screening Programme (NHS BSP), www.cancerscreening.nhs.uk/
breastscreen/ was asked about the ‘‘1 in 9’’ breast cancer inci-
dence ﬁgure still being used in screening invitations to 50-
yr-old asymptomatic women (1,782,381 women invited in
2005/20062) when they are also given the NHS BSP breast cancer
awareness code which includes: ‘‘Go for breast screening every 3
years if you are over 50.’’ It is reported that Professor Patnick’s
Eureka moment came when she was going to work, when she
saw ‘‘1 in 9’’ on an advert on the back of a bus she was following,
which, she says, made her realise that if they didn’t use that
ﬁgure in the NHS BSP ‘Breast Screening; the facts’3 leaﬂet, they
were going to confuse women. This patronising and (m)paternal-
istic approach gives no recognition that some women might
reasonably decide that they would prefer to at least ‘consider
the offer’4 (a new approach to communicating about screening
and decision-making), or make an informed decision, leading
perhaps to a more satisfactory and satisfying conclusion, rather
than being told what to do.1. Responsibilities of support and advocacy organisations
Jane Hatﬁeld, the other of the two women, is director of policy
and campaigns at Breast Cancer Care www.breastcancercare.
org.uk/. When challenged about use of this slogan contributing to
the fear so eloquently described by Emeritus Professor Cornelia
Baines, Department of Public Health Sciences, University of Tor-
onto,1 she admitted that ‘‘we [awareness advocates] don’t always
get it right’’. Both Patnick and Hatﬁeld countered Dr. McCartney’s
challengewhether consistency should trump accuracy, by afﬁrming
that they stressed the link between age and risk on their websites –
this, in spite of the fact that Patnick was one of the three authors of
a paper reporting on a survey which showed that less than 1% of
women knew that the risk for breast cancer was highest in the old-
est age groups.5 Breast cancer support and advocacy organisations
have a high public proﬁle and exert considerable inﬂuence over
large numbers of women. It is essential that they recognise their
responsibilities. They should refrain from scare-mongering tactics1743-9191/$ – see front matter  2008 Surgical Associates Ltd. Published by Elsevier Lt
doi:10.1016/j.ijsu.2008.10.002that engender unreasonable fear in people who do not understand
the statistics and who have been persuaded, coerced and manipu-
lated by literature promoting uncertain beneﬁts but is short on
mentioning known harms. As Don Berry, statistician and professor
of Cancer Research at the University of Texas, said when advocating
what people should be told1: ‘‘These are the beneﬁts as we know
them – they are uncertain. These are the risks as we know them –
and these are more certain.’’
Dr. Joan Austoker, Director of Cancer Research UK’s Primary Care
Education Research Group at the University of Oxford, has been
leading a project to evaluate the information currently available
for public and primary care audiences. She reports in the NHS
BSP annual review 20072 (which this year celebrates its 20th Anni-
versary): ‘‘We’ve never had a comprehensive set of standards
which outline the key information that should be included in every
invitation letter, sowe’ve never really been able to achieve a consis-
tency in the messages we’ve been delivering.’’ Yet in that twenty
years they seem to have been deaf to a campaign that has been
waged for availability of better, more balanced information – infor-
mation that is as accurate as possible – not information that is
‘popular’ or used so as ‘not to confuse’, or that panders to ‘belief’,
rather than being based on the best available facts.62. Organisations at odds with presenting ‘reality’
As Baines said, critics of breast cancer screening face an uphill
battle. She reports how, when she had been on the advisory
committee of a very large cancer voluntary organisation, discussing
scientiﬁc issues about breast screening, their recommendations
were not accepted because ‘‘they are counter to the beliefs of the
fundraising volunteers and their support is essential’’. Don Berry
reports a similar reaction when he served on a National Institutes
of Health consensus development panel in 1997 drawing up guide-
lines for screening women in their forties for breast cancer. Their
recommendation that women be given information about positives
and negatives associated with screening and allowed to make their
own decisions about whether to be screened in consultation with
their doctors, was met with personal viliﬁcation when reported
in the press. One is led to wonder how the best interests of women
are to be served in view of these damaging symbiotic relationships
that discourage open and truthful communication and hinder
enlightenment.d. All rights reserved.
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A recent editorial giving a global perspective on breast cancer
presented data showing the extremes of incidence and mortality
rates in some resource-rich developed regions and resource-poor
regions: it repays close scrutiny. It shows that, although breast
cancer incidence is substantially higher in the more afﬂuent devel-
oped countries, breast cancer mortality rates are similar when
comparing rich and poor, especially for women in younger age
groups.7 One contributing factor to the high incidence rates in
developed regions is that over-zealous early detection by increas-
ingly sophisticated technological methods – even including proposals
for use of MRI to detect pure ductal carcinoma in situ8 – increases
incidence with little beneﬁt in reducing mortality or prolonging
life. At the same time, these early detection initiatives expend
huge ﬁnancial resources to produce unnecessary morbidity for
large numbers of women.9
4. Trust
It is to be hoped that providers of screening programmes and
organisations providing information and support to women will
recognise the importance of the need for a more realistic approach
to communicating honestly about screening, as advocated by
Entwistle and colleagues in their paper published in the British
Medical Journal October 2008.4 More importantly, they must lose
no time in acting on it if they truly have the best interests of women
at heart. Trust once lost is difﬁcult, or even impossible to regain.
I can do no better than quote part of Margaret McCartney’s
concluding paragraph with her plea for ‘‘a reality check’’ about
the use of ‘‘1 in 9’’:
‘‘.if doctors and researchers want patients to trust them, they
need to talk to those patients – all of them, not just the haema-
tologists among them – as people needing both information andempathy. Pushing women towards breast cancer screening and
every intervention available for the disease is, in the end, not
always the same thing as caring about their health’’.Conﬂict of interest
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